Researchers have developed a robotic system to enhance the accuracy and efficiency of drug testing for cancer. The new technology automates the process of identifying rare cancer cells that may survive initial treatment, a key indicator of potential relapse. Traditional methods of detection are often manual and prone to human error, potentially missing these critical cells. The robotic system uses advanced imaging and analysis to scan samples with greater precision and speed. This improved detection allows scientists to better assess the effectiveness of cancer drugs and tailor treatments accordingly. Early trials demonstrate the system’s ability to identify these elusive cells more reliably, offering hope for more effective cancer therapies and improved patient outcomes. The technology promises to accelerate drug development and personalize cancer care.